LUNG CAVITATION: AN UNWANTED COMPLICATION OF COVID-19 LUNG DISEASE

Abstract

Aim & objective: To assess the incidence of pulmonary cavitatory lesion in patients with COVID-19 and describe its characteristics and evolution. The present descriptive observational study Methodology: was conducted on 1105 RT-PCR Conrmed cases of SARS-COV-19 in Sri AUROBINDO MEDICAL COLLEGE AND PG INSTITUTE, INDORE, Madhya Pradesh january 2021 to june 2021. This study highlights t Conclusion: hat lung cavitatory lesion in patients with severe COVID-19 lung disease can occur, is associated with secondary complications of hemoptysis, pneumothorax, and confers a poor prognosis. Early cross sectional imaging should be considered if there is suspicion of cavitatory lesion on plain radiographs, and a more aggressive investigation and treatment of possible invasive fungal infection undertaken. Further studies are needed to determine whether treatment with tocilizumab, systemic glucocorticoids or a combination of both may increase the risk of developing lung cavitatory lesion in patients with COVID-19.